<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>htar Arkiv - NHTA</title>
	<atom:link href="https://nhta.com/tag/htar/feed/" rel="self" type="application/rss+xml" />
	<link>https://nhta.com/tag/htar/</link>
	<description></description>
	<lastBuildDate>Tue, 07 Apr 2026 14:11:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://nhta.com/wp-content/uploads/2025/06/favicon-150x150.png</url>
	<title>htar Arkiv - NHTA</title>
	<link>https://nhta.com/tag/htar/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Bestillerforum reviewed nine methods and updated two cases</title>
		<link>https://nhta.com/bestillerforum-reviewed-nine-methods-and-updated-two-cases/</link>
		
		<dc:creator><![CDATA[NHTA]]></dc:creator>
		<pubDate>Mon, 16 Mar 2026 15:10:43 +0000</pubDate>
				<category><![CDATA[Insights]]></category>
		<category><![CDATA[hta]]></category>
		<category><![CDATA[htar]]></category>
		<category><![CDATA[method review]]></category>
		<category><![CDATA[nye metoder]]></category>
		<guid isPermaLink="false">https://nhta.com/bestillerforum-reviewed-nine-methods-and-updated-two-cases/</guid>

					<description><![CDATA[<p>Norway’s Bestillerforum for new methods has completed its meeting on 16 March 2026, and a preliminary protocol has been published. Methods discussed (nine total): Medicines (seven): mepolizumab (Nucala) for uncontrolled COPD with elevated eosinophils; mirdametinib (Ezmekly) for inoperable plexiform neurofibromas in NF1 (paediatric and adult requests); nirogacestat (Ogsiveo) for progressive desmoid tumours; rilzabrutinib (Wayrilz) for...</p>
<p>Indlægget <a href="https://nhta.com/bestillerforum-reviewed-nine-methods-and-updated-two-cases/">Bestillerforum reviewed nine methods and updated two cases</a> blev først udgivet på <a href="https://nhta.com">NHTA</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Norway’s <strong>Bestillerforum for new methods</strong> has completed its meeting on 16 March 2026, and a preliminary protocol has been published.</p>
<p><strong>Methods discussed (nine total):</strong></p>
<ul>
<li><strong>Medicines (seven):</strong> mepolizumab (Nucala) for uncontrolled COPD with elevated eosinophils; mirdametinib (Ezmekly) for inoperable plexiform neurofibromas in NF1 (paediatric and adult requests); nirogacestat (Ogsiveo) for progressive desmoid tumours; rilzabrutinib (Wayrilz) for refractory ITP; nivolumab (Opdivo) + AVD for previously untreated stage III–IV classical Hodgkin lymphoma (≥12 years); lanadelumab (Takhzyro) extension to ages 2–11 for hereditary angioedema prophylaxis; tiratrikol (Emcitate) for peripheral thyrotoxicosis in MCT8 deficiency.</li>
<li><strong>Medical devices/diagnostics (two):</strong> DynamX coronary stent for PCI; Airsonett Air 4 (temperature-controlled laminar airflow) for severe allergic asthma.</li>
</ul>
<p><strong>Updated assignment:</strong> apremilast for oral ulcers associated with Behçet’s disease (ID2019_099).</p>
<p><strong>Cancelled assignments:</strong> acalabrutinib (Calquence) + bendamustine + rituximab for untreated mantle cell lymphoma (ID2024_082); AI-based analysis of epileptic seizures (Nelli®) (ID2025_019).</p>
<p>Read more at <a href="https://www.nyemetoder.no/aktuelt/160326-bestillerforum/" target="_blank" rel="noopener noreferrer nofollow">https://www.nyemetoder.no/aktuelt/160326-bestillerforum/</a></p>
<p>Indlægget <a href="https://nhta.com/bestillerforum-reviewed-nine-methods-and-updated-two-cases/">Bestillerforum reviewed nine methods and updated two cases</a> blev først udgivet på <a href="https://nhta.com">NHTA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
